A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors.

Cancers (Basel) · 2026 · PMC13162698 · PMID 42122126

Europe PMC DOI

hedged sentences

0.0856

closest p · 1.7× alpha

0.6030

boldest claim

The sentences

a positive trendp = 0.0856so close (0.05 < p ≤ 0.1)

Subgroup analysis revealed a positive trend in reflux symptom management in the WECARE group ( p = 0.0856).

also in 6,779 other papers

did not reach statistical significancep = 0.603not close (p > 0.1)

Although the between-group difference at 6 months did not reach statistical significance (difference: 0.462; p = 0.603; Cohen’s d = −0.065), the longitudinal trajectory in the WECARE group appeared more favorable from the acute postoperative period onward ( Table 2 , Figure 2 ). 3.3.

also in 74,032 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.